Critical Insights From Werewolf Therapeutics Analyst Ratings: What You Need To Know
Critical Insights From Werewolf Therapeutics Analyst Ratings: What You Need To Know
Werewolf Therapeutics分析師評級的關鍵見解：你需要知道的
In the latest quarter, 5 analysts provided ratings for Werewolf Therapeutics (NASDAQ:HOWL), showcasing a mix of bullish and bearish perspectives.
在最近一個季度中，有5位分析師爲狼人療法（納斯達克股票代碼：HOWL）提供了評級，顯示了看漲和看跌的觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have recently evaluated Werewolf Therapeutics and provided 12-month price targets. The average target is $13.8, accompanied by a high estimate of $15.00 and a low estimate of $12.00. Observing a downward trend, the current average is 8.0% lower than the prior average price target of $15.00.
分析師最近對Werewolf Therapeutics進行了評估，並提供了12個月的目標股價。平均目標爲13.8美元，最高估計值爲15.00美元，低估值爲12.00美元。觀察下降趨勢，當前的平均價格比之前的平均目標價15.00美元低8.0％。
Investigating Analyst Ratings: An Elaborate Study
調查分析師評級：一項詳盡的研究
The standing of Werewolf Therapeutics among financial experts is revealed...
通過對近期分析師行爲...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。